Editor - Pradeep K. Karla | Howard University | 5953
ISSN: 2161-0479

Journal of Autacoids and Hormones
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Pradeep K. Karla

Pradeep K. Karla
Pradeep K. Karla
School of Pharmacy
Howard University
Howard University


Dr. Pradeep K. Karla is an Assistant Professor in Pharmaceutical Sciences at Howard University, School of Pharmacy. The significance of Dr. Karla’s research involves the discovery of new drug efflux transporters on human ocular tissue, Cornea, which forms the primary barrier for topical ocular drug delivery. Dr. Karla’s research have demonstrated for the first time that these transporters play a vital role in decreased ocular bioavailability of drugs employed in chronic disease states such as glaucoma and ocular herpes. In-vivo ocular microdialysis studies in rabbit animal model have demonstrated promising results, where ocular bioavailability improved significantly with modulation of the transporters. 

Research Interest

Dr. Karla is interested in implementing new technologies to promote active learning in classroom. Dr. Karla’s research in teaching method development involves integrating tablet touch interface of faculty and student tablet PC’s via Wi-Fi network to create a real time interactive platform.Current research in our laboratory involves the screening of wide array of ocular drugs for substrate specificity of the multiple drug efflux transporters identified and testing of nano-ophthalmic/pro-drug strategies as drug delivery options for improved bioavailability. The long-term goal would be to develop an efficient ophthalmic drug delivery strategy for improved ocular bioavailability of drugs administered topically. 



Global Speakers in the subject

Global Experts in the subject